Table 1.
Characterization and validation.
| Classification | Test | Result | Data |
|---|---|---|---|
| Morphology | Photography | Visual record of the line: normal | Fig. 1 panel A |
| Phenotype | Qualitative analysis: Immunofluorescence staining | Positive expression of pluripotency markers: Oct3/4, Nanog, Sox2 | Fig. 1 panel C |
| Quantitative analysis: RT-qPCR | NANOG and SOX2 expressed in the iPSC lines and absent in differentiated CMs | Fig. 1 panel D | |
| Genotype | Whole genome array (KaryoStat™ Assay) Resolution 1–2 Mb | Normal karyotype: SCVIi063-A 46, XX SCVIi064-A 46, XY |
Supplementary Fig. 1 panel A |
| Identity | STR analysis | 16 loci tested match well | Submitted in archive with authors |
| Microbiology and virology | Mycoplasma | Mycoplasma testing by luminescence: Negative | Supplementary Fig. 1 panel B |
| Differentiation potential | Directed differentiation | Positive IF staining of three germ layer markers | Fig. 1 panel E |
| Germ layer markers | Expression of these markers demonstrated at mRNA (RT-PCR) and protein (IF) levels | Ectoderm: Pax6, Otx2 Endoderm: Sox17, Foxa2 Mesoderm: Brachyury, Tbx6 |
Fig. 1 panel E |
| Mutation analysis | Sequencing | Heterozygous | Fig. 1 panel F |